Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remo Guerrini

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
European Journal of Pharmacology|September 15, 2004
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptorsValeria Camarda, Wei Song, Erika Marzola, et al.
Journal of Medicinal Chemistry|January 24, 2014
Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growthMichela Pelà, Puneet Saxena, Rosaria Luciani, et al.
Journal of Proteome Research|September 24, 2016
Correction to "Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides"Filippo Genovese, Alessandra Gualandi, Laura Taddia, et al.
Journal of Proteome Research|September 9, 2014
Mass spectrometric/bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptidesFilippo Genovese, Alessandra Gualandi, Laura Taddia, et al.
Journal of Medicinal Chemistry|March 18, 2021
Structure-Activity Relationship Studies on Oxazolo[3,4-<i>a</i>]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent <i>In Vivo</i> ActivityValentina Albanese, Chiara Ruzza, Erika Marzola, et al.
Journal of Medicinal Chemistry|November 4, 2025
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric LigandsValentina Albanese, Pietro Pola, Michela Argentieri, et al.
British Journal of Pharmacology|November 8, 2005
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803)Valeria Camarda, Martina Spagnol, Wei Song, et al.
Pharmacology, Biochemistry, and Behavior|September 11, 2012
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in miceSaulo Fábio Ramos, Bruna Pescador Mendonça, Daniela Dimer Leffa, et al.
Journal of Medicinal Chemistry|March 12, 2021
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface TargetingGaetano Marverti, Chiara Marraccini, Andrea Martello, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 21, 2005
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's diseaseMatteo Marti, Flora Mela, Martina Fantin, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
European Journal of Pharmacology|September 15, 2004
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptorsValeria Camarda, Wei Song, Erika Marzola, et al.
Journal of Medicinal Chemistry|January 24, 2014
Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growthMichela Pelà, Puneet Saxena, Rosaria Luciani, et al.
Journal of Proteome Research|September 24, 2016
Correction to "Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides"Filippo Genovese, Alessandra Gualandi, Laura Taddia, et al.
Journal of Proteome Research|September 9, 2014
Mass spectrometric/bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptidesFilippo Genovese, Alessandra Gualandi, Laura Taddia, et al.
Journal of Medicinal Chemistry|March 18, 2021
Structure-Activity Relationship Studies on Oxazolo[3,4-<i>a</i>]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent <i>In Vivo</i> ActivityValentina Albanese, Chiara Ruzza, Erika Marzola, et al.
Journal of Medicinal Chemistry|November 4, 2025
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric LigandsValentina Albanese, Pietro Pola, Michela Argentieri, et al.
British Journal of Pharmacology|November 8, 2005
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803)Valeria Camarda, Martina Spagnol, Wei Song, et al.
Pharmacology, Biochemistry, and Behavior|September 11, 2012
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in miceSaulo Fábio Ramos, Bruna Pescador Mendonça, Daniela Dimer Leffa, et al.
Journal of Medicinal Chemistry|March 12, 2021
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface TargetingGaetano Marverti, Chiara Marraccini, Andrea Martello, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 21, 2005
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's diseaseMatteo Marti, Flora Mela, Martina Fantin, et al.
Pageof 22